Koch T, Dahlke C, Fathi A, Kupke A, et al. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet Infect Dis 2020 Apr 20. pii: S1473-3099(20)30248.
PMID: 32325037